VIDEO: EyeMax Mono IOL beneficial for patients with insignificant cataract, dry AMD

ByFederico Badalà, MD

ByMichela Cimberle

Fact checked byChristine Klimanskis, ELS

BARCELONA, Spain — In this Healio Video Perspective from the ESCRS meeting, Federico Badalà, MD, shares his experience with the EyeMax Mono IOL in patients with insignificant cataract and dry age-related macular degeneration.

“I started using this lens in 2015 ... with very advanced cases,” he said. “Since we got quite excited with the results of this lens, we then moved into patients who were younger and with less advanced disease. In the last 5 years, we actually realized that patients with minimal cataract, starting AMD or starting any form of macular disease would benefit quite well from this product.”

EyeMax Mono (SharpView Ophthalmology) improves quality of vision up to 10° of eccentricity from the central fovea and can benefit patients with macular damage limited to the center of the fovea, according to Badalà.

Published by:

Sources/Disclosures

Collapse

Source:

Badalà F. Long-term safety and efficacy of an extended macular vision intraocular lens (IOL) implanted in patients with macular disease undergoing cataract extraction, with a focus on results of visually insignificant cataract eyes. Presented at: European Society of Cataract and Refractive Surgeons meeting; Sept. 6-10, 2024; Barcelona, Spain.

Disclosures: Badalà reports no relevant financial disclosures.

European Society of Cataract and Refractive Surgeons Meeting

Read more

VIDEO: EyeMax Mono IOL beneficial for patients with insignificant cataract, dry AMD

Related Content